サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1678685

そう痒症治療の市場規模、シェア、動向分析レポート：疾患別、製品別、流通チャネル別、地域別、セグメント予測、2025年～2030年

Pruritus Therapeutics Market Size, Share & Trends Analysis Report By Disease, By Product, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.08円
そう痒症治療の市場規模、シェア、動向分析レポート：疾患別、製品別、流通チャネル別、地域別、セグメント予測、2025年～2030年
出版日: 2025年02月11日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

そう痒症治療市場の成長と動向

Grand View Research, Inc.の最新レポートによると、そう痒症治療の世界市場規模は2030年までに113億4,000万米ドルに達し、2025～2030年のCAGRは4.1％を記録すると予測されています。

アトピー性皮膚炎、アレルギー性接触皮膚炎、蕁麻疹の世界の有病率の増加が、予測期間中の市場成長を促進すると見られています。新たなT細胞サブセット、特にTh17、Th22の同定やプロトピック（タクロリムス）の特許切れなど、科学的なメカニズム解明による新製品の導入は、予測期間中、メーカーにとって新たな活路を開くものと期待されます。

副腎皮質ステロイドは、炎症とかゆみを抑えることでそう痒症の治療に高い効果を発揮することから、2013年の主要製品セグメントとなっています。コルチコステロイドの局所適用は、そう痒症の治療と維持療法に非常に有効であることが判明しています。

そう痒症治療市場レポートハイライト

  • 副腎皮質ステロイドが市場を独占し、2024年には28.1%のシェアを占めます。抗ヒスタミン薬は予測期間中に大幅な成長が見込まれます。
  • 病院薬局が市場を独占し、2024年には49.8%のシェアを占めます。オンライン薬局は予測期間中にCAGR 5.9%で最速の成長が予測されます。
  • 北米のそう痒症治療市場は、2024年に38.7%の収益シェアで世界市場を独占しました。米国のそう痒症治療市場は、2024年に90.1%の収益シェアで北米のそう痒症治療市場を独占しました。
  • アジア太平洋のそう痒症治療市場は、予測期間中に最速のCAGR 6.1%を記録する見込みです。アジア太平洋市場の中で、インドの掻痒症治療市場が予測期間中に最も速い速度で成長すると予測されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 そう痒症治療市場の変数、動向、範囲

  • 市場系統の展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • ビジネス環境分析
    • 産業分析-ポーターのファイブフォース分析
    • PESTLE分析

第4章 そう痒症治療市場：疾患ビジネス分析

  • 疾患市場シェア、2024年と2030年
  • 疾患セグメントダッシュボード
  • 市場規模と予測と動向分析、疾患別、2018～2030年
  • アトピー性皮膚炎
  • アレルギー性接触皮膚炎
  • 蕁麻疹
  • その他

第5章 そう痒症治療市場：製品ビジネス分析

  • 製品市場シェア、2024年と2030年
  • 製品セグメントダッシュボード
  • 市場規模と予測と動向分析、製品別、2018～2030年
  • コルチコステロイド
  • 抗ヒスタミン薬
  • 局所麻酔薬
  • 抗刺激剤
  • 免疫抑制剤
  • カルシニューリン阻害剤
  • その他

第6章 そう痒症治療市場：流通チャネルビジネス分析

  • 流通チャネル市場シェア、2024年と2030年
  • 流通チャネルセグメントダッシュボード
  • 市場規模と予測と動向分析、流通チャネル別、2018～2030年
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第7章 そう痒症治療市場：地域別、推定・動向分析

  • 地域別市場シェア分析、2024年と2030年
  • 地域別市場ダッシュボード
  • 市場規模、予測動向分析、2018～2030年
  • 北米
    • 国別、2018～2030年
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 国別、2018～2030年
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • デンマーク
    • スウェーデン
  • アジア太平洋
    • 国別、2018～2030年
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • 国別、2018～2030年
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 国別、2018～2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 参加者概要
  • 企業の市況分析
  • 企業分類
  • 戦略マッピング
  • 企業プロファイル/上場企業
    • AbbVie Inc.
    • Amgen, Inc.
    • Astellas Pharma Inc.
    • Bristol-Myers Squibb
    • Cara Therapeutics
    • GSK plc
    • Novartis AG
    • Pfizer Inc.
    • Sanofi
    • Teva Pharmaceutical Industries Ltd
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global pruritus therapeutics market, by region, 2018 - 2030 (USD Million)
  • Table 4 Global pruritus therapeutics market, by disease, 2018 - 2030 (USD Million)
  • Table 5 Global pruritus therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 6 Global pruritus therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 7 North America pruritus therapeutics market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America pruritus therapeutics market, by disease, 2018 - 2030 (USD Million)
  • Table 9 North America pruritus therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 10 North America pruritus therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 11 U.S. pruritus therapeutics market, by disease, 2018 - 2030 (USD Million)
  • Table 12 U.S. pruritus therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 13 U.S. Pruritus therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 14 Canada pruritus therapeutics market, by disease, 2018 - 2030 (USD Million)
  • Table 15 Canada pruritus therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 16 Canada pruritus therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 17 Mexico pruritus therapeutics market, by disease, 2018 - 2030 (USD Million)
  • Table 18 Mexico pruritus therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 19 Mexico pruritus therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 20 Europe pruritus therapeutics market, by country, 2018 - 2030 (USD Million)
  • Table 21 Europe pruritus therapeutics market, by disease, 2018 - 2030 (USD Million)
  • Table 22 Europe pruritus therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 23 Europe pruritus therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 24 UK pruritus therapeutics market, by disease, 2018 - 2030 (USD Million)
  • Table 25 UK pruritus therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 26 UK Pruritus therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 27 Germany pruritus therapeutics market, by disease, 2018 - 2030 (USD Million)
  • Table 28 Germany pruritus therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 29 Germany pruritus therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 30 France pruritus therapeutics market, by disease, 2018 - 2030 (USD Million)
  • Table 31 France pruritus therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 32 France Pruritus therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 33 Italy pruritus therapeutics market, by disease, 2018 - 2030 (USD Million)
  • Table 34 Italy pruritus therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 35 Italy pruritus therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 36 Spain pruritus therapeutics market, by disease, 2018 - 2030 (USD Million)
  • Table 37 Spain pruritus therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 38 Spain pruritus therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 39 Norway pruritus therapeutics market, by disease, 2018 - 2030 (USD Million)
  • Table 40 Norway pruritus therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 41 Norway Pruritus therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 42 Denmark pruritus therapeutics market, by disease, 2018 - 2030 (USD Million)
  • Table 43 Denmark pruritus therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 44 Denmark pruritus therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 45 Sweden pruritus therapeutics market, by disease, 2018 - 2030 (USD Million)
  • Table 46 Sweden pruritus therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 47 Sweden pruritus therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific pruritus therapeutics market, by country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific pruritus therapeutics market, by disease, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific pruritus therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific pruritus therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 52 Japan pruritus therapeutics market, by disease, 2018 - 2030 (USD Million)
  • Table 53 Japan pruritus therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 54 Japan pruritus therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 55 China pruritus therapeutics market, by disease, 2018 - 2030 (USD Million)
  • Table 56 China pruritus therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 57 China pruritus therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 58 India pruritus therapeutics market, by disease, 2018 - 2030 (USD Million)
  • Table 59 India pruritus therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 60 India pruritus therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 61 Australia pruritus therapeutics market, by disease, 2018 - 2030 (USD Million)
  • Table 62 Australia pruritus therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 63 Australia pruritus therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 64 South Korea pruritus therapeutics market, by disease, 2018 - 2030 (USD Million)
  • Table 65 South Korea pruritus therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 66 South Korea pruritus therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 67 Thailand pruritus therapeutics market, by disease, 2018 - 2030 (USD Million)
  • Table 68 Thailand pruritus therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 69 Thailand pruritus therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 70 Latin America pruritus therapeutics market, by country, 2018 - 2030 (USD Million)
  • Table 71 Latin America pruritus therapeutics market, by disease, 2018 - 2030 (USD Million)
  • Table 72 Latin America pruritus therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 73 Latin America pruritus therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 74 Brazil pruritus therapeutics market, by disease, 2018 - 2030 (USD Million)
  • Table 75 Brazil pruritus therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 76 Brazil pruritus therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 77 Argentina pruritus therapeutics market, by disease, 2018 - 2030 (USD Million)
  • Table 78 Argentina pruritus therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 79 Argentina pruritus therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Pruritus therapeutics market, by country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa pruritus therapeutics market, by disease, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa pruritus therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa pruritus therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 84 South Africa pruritus therapeutics market, by disease, 2018 - 2030 (USD Million)
  • Table 85 South Africa pruritus therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 86 South Africa pruritus therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia pruritus therapeutics market, by disease, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia pruritus therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia pruritus therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 90 UAE pruritus therapeutics market, by disease, 2018 - 2030 (USD Million)
  • Table 91 UAE pruritus therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 92 UAE pruritus therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 93 Kuwait pruritus therapeutics market, by disease, 2018 - 2030 (USD Million)
  • Table 94 Kuwait pruritus therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 95 Kuwait pruritus therapeutics market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Pruritus therapeutics market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Disease and product outlook (USD Million)
  • Fig. 10 Distribution channel outlook (USD Million)
  • Fig. 11 Competitive landscape
  • Fig. 12 Pruritus therapeutics market dynamics
  • Fig. 13 Pruritus therapeutics market: Porter's five forces analysis
  • Fig. 14 Pruritus therapeutics market: PESTLE analysis
  • Fig. 15 Pruritus therapeutics market: Disease segment dashboard
  • Fig. 16 Pruritus therapeutics market: Disease market share analysis, 2024 & 2030
  • Fig. 17 Atopic dermatitis market, 2018 - 2030 (USD Million)
  • Fig. 18 Allergic contact dermatitis market, 2018 - 2030 (USD Million)
  • Fig. 19 Urticaria market, 2018 - 2030 (USD Million)
  • Fig. 20 Others market, 2018 - 2030 (USD Million)
  • Fig. 21 Pruritus therapeutics market: Product segment dashboard
  • Fig. 22 Pruritus therapeutics market: Product market share analysis, 2024 & 2030
  • Fig. 23 Corticosteroids market, 2018 - 2030 (USD Million)
  • Fig. 24 Antihistamines market, 2018 - 2030 (USD Million)
  • Fig. 25 Local anesthetics market, 2018 - 2030 (USD Million)
  • Fig. 26 Counterirritants market, 2018 - 2030 (USD Million)
  • Fig. 27 Immunosuppressant market, 2018 - 2030 (USD Million)
  • Fig. 28 Calcineurin inhibitors market, 2018 - 2030 (USD Million)
  • Fig. 29 Others market, 2018 - 2030 (USD Million)
  • Fig. 30 Pruritus therapeutics market: Distribution channel segment dashboard
  • Fig. 31 Pruritus therapeutics market: Distribution channel market share analysis, 2024 & 2030
  • Fig. 32 Hospital pharmacies market, 2018 - 2030 (USD Million)
  • Fig. 33 Retail pharmacies market, 2018 - 2030 (USD Million)
  • Fig. 34 Online pharmacies market, 2018 - 2030 (USD Million)
  • Fig. 35 Pruritus therapeutics market revenue, by region
  • Fig. 36 Regional marketplace: Key takeaways
  • Fig. 37 Regional marketplace: Key takeaways
  • Fig. 38 North America pruritus therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 39 U.S. country dynamics
  • Fig. 40 U.S. pruritus therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 41 Canada country dynamics
  • Fig. 42 Canada pruritus therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 43 Mexico country dynamics
  • Fig. 44 Mexico pruritus therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 45 Europe pruritus therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 46 UK country dynamics
  • Fig. 47 UK pruritus therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 48 Germany country dynamics
  • Fig. 49 Germany pruritus therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 50 France country dynamics
  • Fig. 51 France pruritus therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 52 Italy country dynamics
  • Fig. 53 Italy pruritus therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 54 Spain country dynamics
  • Fig. 55 Spain pruritus therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 56 Norway country dynamics
  • Fig. 57 Norway pruritus therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 58 Sweden country dynamics
  • Fig. 59 Sweden pruritus therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 60 Denmark country dynamics
  • Fig. 61 Denmark pruritus therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 62 Asia Pacific pruritus therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 63 Japan country dynamics
  • Fig. 64 Japan pruritus therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 65 China country dynamics
  • Fig. 66 China pruritus therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 67 India country dynamics
  • Fig. 68 India pruritus therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 69 Australia country dynamics
  • Fig. 70 Australia pruritus therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 71 South Korea country dynamics
  • Fig. 72 South Korea pruritus therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 73 Thailand country dynamics
  • Fig. 74 Thailand pruritus therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 75 Latin America pruritus therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 76 Brazil country dynamics
  • Fig. 77 Brazil pruritus therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 78 Argentina country dynamics
  • Fig. 79 Argentina pruritus therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 80 MEA pruritus therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 81 South Africa country dynamics
  • Fig. 82 South Africa pruritus therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 83 Saudi Arabia country dynamics
  • Fig. 84 Saudi Arabia pruritus therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 85 UAE country dynamics
  • Fig. 86 UAE pruritus therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 87 Kuwait country dynamics
  • Fig. 88 Kuwait pruritus therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 89 Company categorization
  • Fig. 90 Company market position analysis
  • Fig. 91 Strategic framework
目次
Product Code: 978-1-68038-365-2

Pruritus Therapeutics Market Growth & Trends:

The global Pruritus Therapeutics market size is expected to reach USD 11.34 billion by 2030, registering a CAGR of 4.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. Growing worldwide prevalence of atopic dermatitis, allergic contact dermatitis, and urticaria is expected to drive market growth during the forecast period. The introduction of new products based on scientific mechanistic understanding such as the identification of new T-cell subsets, particularly Th17, and Th22 and the patent expiration of PROTOPIC (tacrolimus) is expected to open up new avenues for manufacturers to capitalize on over the forecast period.

Corticosteroids were the leading product segment in 2013 owing to high efficacy exhibited by this class of drugs in treating pruritic conditions by reducing inflammation and itching. Topical applications of corticosteroids have been found to be extremely effective in the treatment and maintenance therapies pertaining to pruritus.

Pruritus Therapeutics Market Report Highlights:

  • Corticosteroids dominated the market and accounted for a share of 28.1% in 2024. Antihistamines are expected to register significant growth over the forecast period.
  • Hospital pharmacies dominated the market and accounted for a share of 49.8% in 2024. Online pharmacies are projected to grow at the fastest CAGR of 5.9% over the forecast period.
  • North America pruritus therapeutics market dominated the global market with a revenue share of 38.7% in 2024. The pruritus therapeutics market in the U.S. dominated the North America pruritus therapeutics market with a revenue share of 90.1% in 2024.
  • Asia Pacific pruritus therapeutics market is expected to register the fastest CAGR of 6.1% in the forecast period. India pruritus therapeutics market is expected to grow at the fastest rate over the forecast period in the Asia Pacific market.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Disease
    • 1.2.2. Product
    • 1.2.3. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Pruritus Therapeutics Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Pruritus Therapeutics Market: Disease Business Analysis

  • 4.1. Disease Market Share, 2024 & 2030
  • 4.2. Disease Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Disease, 2018 to 2030 (USD Million)
  • 4.4. Atopic Dermatitis
    • 4.4.1. Atopic Dermatitis Market, 2018 - 2030 (USD Million)
  • 4.5. Allergic Contact Dermatitis
    • 4.5.1. Allergic Contact Dermatitis Market, 2018 - 2030 (USD Million)
  • 4.6. Urticaria
    • 4.6.1. Urticaria Market, 2018 - 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Pruritus Therapeutics Market: Product Business Analysis

  • 5.1. Product Market Share, 2024 & 2030
  • 5.2. Product Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 5.4. Corticosteroids
    • 5.4.1. Corticosteroids Market, 2018 - 2030 (USD Million)
  • 5.5. Antihistamines
    • 5.5.1. Antihistamines Market, 2018 - 2030 (USD Million)
  • 5.6. Local Anesthetics
    • 5.6.1. Local Anesthetics Market, 2018 - 2030 (USD Million)
  • 5.7. Counterirritants
    • 5.7.1. Counterirritants Market, 2018 - 2030 (USD Million)
  • 5.8. Immunosuppressant
    • 5.8.1. Immunosuppressant Market, 2018 - 2030 (USD Million)
  • 5.9. Calcineurin Inhibitors
    • 5.9.1. Calcineurin Inhibitors Market, 2018 - 2030 (USD Million)
  • 5.10. Others
    • 5.10.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Pruritus Therapeutics Market: Distribution Channel Business Analysis

  • 6.1. Distribution Channel Market Share, 2024 & 2030
  • 6.2. Distribution Channel Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
  • 6.4. Hospital Pharmacies
    • 6.4.1. Hospital Pharmacies Market, 2018 - 2030 (USD Million)
  • 6.5. Retail Pharmacies
    • 6.5.1. Retail Pharmacies Market, 2018 - 2030 (USD Million)
  • 6.6. Online Pharmacies
    • 6.6.1. Online Pharmacies Market, 2018 - 2030 (USD Million)

Chapter 7. Pruritus Therapeutics Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America Pruritus Therapeutics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework
      • 7.4.2.3. Competitive Insights
      • 7.4.2.4. U.S. Pruritus Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework
      • 7.4.3.3. Competitive Insights
      • 7.4.3.4. Canada Pruritus Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Regulatory Framework
      • 7.4.4.3. Competitive Insights
      • 7.4.4.4. Mexico Pruritus Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Pruritus Therapeutics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework
      • 7.5.2.3. Competitive Insights
      • 7.5.2.4. UK Pruritus Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework
      • 7.5.3.3. Competitive Insights
      • 7.5.3.4. Germany Pruritus Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework
      • 7.5.4.3. Competitive Insights
      • 7.5.4.4. France Pruritus Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework
      • 7.5.5.3. Competitive Insights
      • 7.5.5.4. Italy Pruritus Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework
      • 7.5.6.3. Competitive Insights
      • 7.5.6.4. Spain Pruritus Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Norway
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework
      • 7.5.7.3. Competitive Insights
      • 7.5.7.4. Norway Pruritus Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework
      • 7.5.8.3. Competitive Insights
      • 7.5.8.4. Denmark Pruritus Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Sweden
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Regulatory Framework
      • 7.5.9.3. Competitive Insights
      • 7.5.9.4. Sweden Pruritus Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Pruritus Therapeutics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework
      • 7.6.2.3. Competitive Insights
      • 7.6.2.4. Japan Pruritus Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework
      • 7.6.3.3. Competitive Insights
      • 7.6.3.4. China Pruritus Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework
      • 7.6.4.3. Competitive Insights
      • 7.6.4.4. India Pruritus Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework
      • 7.6.5.3. Competitive Insights
      • 7.6.5.4. South Korea Pruritus Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework
      • 7.6.6.3. Competitive Insights
      • 7.6.6.4. Australia Pruritus Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Regulatory Framework
      • 7.6.7.3. Competitive Insights
      • 7.6.7.4. Thailand Pruritus Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Pruritus Therapeutics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework
      • 7.7.2.3. Competitive Insights
      • 7.7.2.4. Brazil Pruritus Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Framework
      • 7.7.3.3. Competitive Insights
      • 7.7.3.4. Argentina Pruritus Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA Pruritus Therapeutics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework
      • 7.8.2.3. Competitive Insights
      • 7.8.2.4. South Africa Pruritus Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework
      • 7.8.3.3. Competitive Insights
      • 7.8.3.4. Saudi Arabia Pruritus Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework
      • 7.8.4.3. Competitive Insights
      • 7.8.4.4. UAE Pruritus Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Regulatory Framework
      • 7.8.5.3. Competitive Insights
      • 7.8.5.4. Kuwait Pruritus Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. AbbVie Inc.
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Amgen, Inc.
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Astellas Pharma Inc.
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Bristol-Myers Squibb
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Cara Therapeutics
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. GSK plc
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Novartis AG
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Pfizer Inc.
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. Sanofi
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Teva Pharmaceutical Industries Ltd
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives